Methods of treating concomitant constipation in a cancer treatment regimen including imexon
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 1, 2007
app pub date -
Aug 29, 2006
filing date -
Aug 31, 2005
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods of treating imexon-induced constipation in patients in conjunction with their participation in a cancer treatment regimen are disclosed herein. Embodiments of the invention include the treatment of imexon-induced constipation arising from the administration of imexon alone or in combination with other chemotherapeutic agents. Also disclosed are pharmaceutical compositions and pharmaceutical kits comprising a therapeutically effective amount of imexon and an amount of a laxative effective in treating imexon-induced constipation. Embodiments of the present invention include prophylactic anticonstipation regimens comprising one or more laxatives that may be prescribed and/or administered prior to or during the course of treatment of the patient with imexon.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully